Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 106.60
-1.80 (-1.66%)
Jun 11, 2026, 3:13 PM AST
Dallah Healthcare Company Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Dallah Healthcare Company stock has a consensus rating of "Hold" and an average price target of SAR 130.74. The average 1-year stock price forecast is 22.65% higher than the current stock price, while the lowest is SAR 92.00 (-13.70%) and the highest is SAR 175.00 (+64.17%).
Price Target: SAR 130.74 (+22.65%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Dallah Healthcare Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 3 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 5 | 4 | 3 | 2 | 2 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
4.38B
from 4.07B
Increased by 7.60%
Revenue Next Year
4.76B
from 4.38B
Increased by 8.79%
EPS This Year
4.64
from 5.32
Decreased by -12.75%
EPS Next Year
5.51
from 4.64
Increased by 18.73%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.5B | ||
| Avg | 4.4B | ||
| Low | 4.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.2% | ||
| Avg | 7.6% | ||
| Low | 2.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.79 | ||
| Avg | 4.64 | ||
| Low | 4.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -9.9% | ||
| Avg | -12.8% | ||
| Low | -16.4% |